Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

A PharmaVitae Profile of Genentech Inc: Benchmark it Against its Rivals, Examine its Financial Performance and Study Sales Forecasts for Key Drugs.


DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River.
, Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles.  -- Research and Markets (http://www.researchandmarkets.com/research/1669a7/genentech_inc_ph) has announced the addition of the "Genentech Genentech Inc. (NYSE: DNA), a composite of Genetic Engineering Technology, Inc., is a leading biotechnology corporation, which was founded in 1976 by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer.  Inc.: PharmaVitae Profile" company profile to their offering.

This analysis examines the historical and forecast performance for Genentech in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts Sales forecast

A key input to a firm's financial planning process. External sales forecasts are based on historical experience, statistical analysis, and consideration of various macroeconomic factors.
 for key drugs. An interactive forecasting and analysis tool provides continually con·tin·u·al  
adj.
1. Recurring regularly or frequently: the continual need to pay the mortgage.

2.
 updated quantitative and qualitative information.

Key reasons to purchase this title

- Benchmark Genentechs performance against key rivals in the prescription pharmaceutical sector

- Assess the importance of Avastin Genentechs commercial performance over 2007-13

- Analyze how Genentech will continue to utilize horizontal indication broadening across its core portfolio to drive sales growth

Key Topics Covered:

- About This Profile

- Quarterly News Update

- Company Introduction

- Company Sales

- Company Financials

- Key Products And Competitors

- Table Of Tables

- Table Of Figures

For more information visit http://www.researchandmarkets.com/research/1669a7/genentech_inc_ph.

Source: Datamonitor
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Company overview
Date:Sep 29, 2008
Words:165
Previous Article:Research and Markets: A Strategic Corporate Assessment of Kellogg: Providing a SWOT Analysis, Company Overview and 5-year Financial Insights.
Next Article:Fitch Rates Apache Corporation's $800MM Issuance 'A'; Outlook to Negative.
Topics:



Related Articles
Understand the Drivers of Novartis's Forecast 5.5% Year-on-Year Growth to 2010.
Benchmark Kings Performance Against Key Rivals in the Ethical Pharmaceutical Sector.
Understand the Driving Factors Behind Seronos Forecast 8.4% CAGR Between 2004 and 2010.
Learn Which Therapeutic Areas Are Forecast to Drive Novartis Growth to 2010.
Understand how Chirons Problems with Vaccines Manufacturing Has Affected its Position within the Global Market.
Reportlinker.com: Get a Deep Insight into Genentech's Strategy in the Ethical Pharmaceutical Sector.
Research and Markets: Benchmark Abbotts Performance Against Key Rivals In The Ethical Pharmaceutical Sector.
Research and Markets: New Report Benchmarks Bayer Schering's Performance against Key Rivals in the Ethical Pharmaceutical Sector.
Research and Markets: Benchmark Genzymes Performance Against Key Rivals in the Ethical Pharmaceutical Sector Today.
Research and Markets: Benchmark Serviers Performance Against Key Rivals In The Ethical Pharmaceutical Sector.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles